AU2001268744A1 - Characterizing a brain tumor - Google Patents

Characterizing a brain tumor

Info

Publication number
AU2001268744A1
AU2001268744A1 AU2001268744A AU6874401A AU2001268744A1 AU 2001268744 A1 AU2001268744 A1 AU 2001268744A1 AU 2001268744 A AU2001268744 A AU 2001268744A AU 6874401 A AU6874401 A AU 6874401A AU 2001268744 A1 AU2001268744 A1 AU 2001268744A1
Authority
AU
Australia
Prior art keywords
characterizing
brain tumor
tumor
brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268744A
Inventor
Waldemar Debinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Penn State Research Foundation
Original Assignee
Penn State Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penn State Research Foundation filed Critical Penn State Research Foundation
Publication of AU2001268744A1 publication Critical patent/AU2001268744A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
AU2001268744A 2000-06-30 2001-06-28 Characterizing a brain tumor Abandoned AU2001268744A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21562300P 2000-06-30 2000-06-30
US60215623 2000-06-30
PCT/US2001/020615 WO2002002799A1 (en) 2000-06-30 2001-06-28 Characterizing a brain tumor

Publications (1)

Publication Number Publication Date
AU2001268744A1 true AU2001268744A1 (en) 2002-01-14

Family

ID=22803727

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268744A Abandoned AU2001268744A1 (en) 2000-06-30 2001-06-28 Characterizing a brain tumor

Country Status (2)

Country Link
AU (1) AU2001268744A1 (en)
WO (1) WO2002002799A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061144A2 (en) * 2001-01-31 2002-08-08 Whitehead Institute For Biomedical Research Brain tumor diagnosis and outcome prediction
JP2005073621A (en) * 2003-09-01 2005-03-24 Japan Science & Technology Agency Marker for cerebral tumor and method for diagnosing cerebral tumor
US8343461B2 (en) 2006-03-08 2013-01-01 Wake Forest University Health Sciences Molecular signature of cancer
EP2946786A1 (en) * 2006-03-08 2015-11-25 Wake Forest University Health Sciences Soluble monomeric Ephrin A1
DE202010002285U1 (en) 2010-02-12 2011-08-23 Ligmatech Automationssysteme Gmbh Device for returning machined workpieces

Also Published As

Publication number Publication date
WO2002002799A1 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
AU2002224520A1 (en) A cannula
AU2002213697A1 (en) Programmable neurostimulator
AU2002222853A1 (en) Therapeutic compounds
AU2001280796A1 (en) Electrowetting-driven micropumping
AU2001231674A1 (en) Pattern
AU2002214471A1 (en) Map-aided positioning
AU2001240856A1 (en) Capsules
AU2000267458A1 (en) Hypercomputer
AU5252400A (en) Concentric plug
AU2002215772A1 (en) Implantable neurostimulator
AU2001240838A1 (en) Capsules
AU2001229461A1 (en) Method for inhibiting a tumor
AU2002239405A1 (en) Tetrapartate prodrugs
AU2001268744A1 (en) Characterizing a brain tumor
AU2001266176A1 (en) Methods
AU2001210572A1 (en) Ornament
HK1041455A1 (en) A cancer thermotherapy
AU2001250536A1 (en) Methods
AU2000279378A1 (en) A bed
AU2001252007A1 (en) Socket-outlet
AU2001289127A1 (en) Tumor treatment
AU2001292897A1 (en) Novel therapy
AU2002220530A1 (en) A lure
AU2001290153A1 (en) A connector
AU4667801A (en) Methods